These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 31624303)
21. Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management. Courcier J; de la Taille A; Nourieh M; Leguerney I; Lassau N; Ingels A Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998233 [TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812 [TBL] [Abstract][Full Text] [Related]
23. Association of the Gross Appearance of Intratumoral Vascularity at MDCT With the Carbonic Anhydrase IX Score in Clear Cell Renal Cell Carcinoma. Young JR; Coy H; Kim HJ; Douek M; Sisk A; Pantuck AJ; Raman SS AJR Am J Roentgenol; 2018 Dec; 211(6):1254-1258. PubMed ID: 30300009 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9. Petrul HM; Schatz CA; Kopitz CC; Adnane L; McCabe TJ; Trail P; Ha S; Chang YS; Voznesensky A; Ranges G; Tamburini PP Mol Cancer Ther; 2012 Feb; 11(2):340-9. PubMed ID: 22147747 [TBL] [Abstract][Full Text] [Related]
27. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers. Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036 [TBL] [Abstract][Full Text] [Related]
28. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast. van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929 [TBL] [Abstract][Full Text] [Related]
29. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453 [TBL] [Abstract][Full Text] [Related]
30. CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models. Li H; Ding J; Lu M; Liu H; Miao Y; Li L; Wang G; Zheng J; Pei D; Zhang Q J Immunother; 2020 Jan; 43(1):16-28. PubMed ID: 31574023 [TBL] [Abstract][Full Text] [Related]
31. The role of molecular imaging in the characterization of renal masses. Meyer AR; Allaf ME; Rowe SP; Gorin MA Curr Opin Urol; 2018 Mar; 28(2):159-165. PubMed ID: 29319547 [TBL] [Abstract][Full Text] [Related]
32. Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma. Zhu W; Li X; Zheng G; Bai C; Ji Z; Zhang H; Xing H; Zhang Y; Huo L Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3116-3125. PubMed ID: 37246998 [TBL] [Abstract][Full Text] [Related]
33. Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology. Xu C; Lo A; Yammanuru A; Tallarico AS; Brady K; Murakami A; Barteneva N; Zhu Q; Marasco WA PLoS One; 2010 Mar; 5(3):e9625. PubMed ID: 20224781 [TBL] [Abstract][Full Text] [Related]
34. Molecular targeting of carbonic anhydrase IX in mice with hypoxic HT29 colorectal tumor xenografts. Carlin S; Khan N; Ku T; Longo VA; Larson SM; Smith-Jones PM PLoS One; 2010 May; 5(5):e10857. PubMed ID: 20523727 [TBL] [Abstract][Full Text] [Related]
36. ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice. Stillebroer AB; Franssen GM; Mulders PF; Oyen WJ; van Dongen GA; Laverman P; Oosterwijk E; Boerman OC Cancer Biother Radiopharm; 2013 Sep; 28(7):510-5. PubMed ID: 23697926 [TBL] [Abstract][Full Text] [Related]
37. Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma. Cui J; Zhang Q; Song Q; Wang H; Dmitriev P; Sun MY; Cao X; Wang Y; Guo L; Indig IH; Rosenblum JS; Ji C; Cao D; Yang K; Gilbert MR; Yao Y; Zhuang Z Neuro Oncol; 2019 Nov; 21(11):1436-1446. PubMed ID: 31276594 [TBL] [Abstract][Full Text] [Related]